Effect of aging on brain metabolism in antiretroviral-naive HIV patients

AIDS

Volumn 18, Issue SUPPL. 1, 2004, Pages

  Ernst, Thomas ^a,b   Chang, Linda ^a,b  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; Brain; Dementia; HIV; Magnetic resonance spectroscopy; Metabolism

Indexed keywords

ACETIC ACID DERIVATIVE; ANTIRETROVIRUS AGENT; CHOLINE; CREATINE; INOSITOL; MARKER;

ADULT; AGING; BASAL GANGLION; BRAIN METABOLISM; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FRONTAL LOBE; GRAY MATTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; METABOLITE; MULTIVARIATE ANALYSIS OF COVARIANCE; PATIENT; PILOT STUDY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SERODIAGNOSIS; WHITE MATTER;

EID: 1642354110     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200401001-00009     Document Type: Conference Paper

References (41)

1. Tracey I, Carr CA, Guimaraes AR, Worth JL, Navia BA, Gonzalez RG. Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: a proton magnetic resonance spectroscopic study. Neurology 1996; 46:783-788.
2. Chang L, Ernst T, Leonido-Yee M, Walot I, Singer E. Cerebral metabolite abnormalities correlate with clinical severity of HIV-cognitive motor complex. Neurology 1999; 52:100-108.
3. Chang L, Ernst T, Witt M, Ames N, Jocivich J, Speck O, et al. Relationships among cerebral metabolites, cognitive function and viral loads in antiretroviral-naive HIV patients. NeuroImage 2002; 17:1638-1648.
4. Sacktor N, Lyles R, Skolasky R, Anderson D, McArthur J, McFarlane G, et al. Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men. Multicenter AIDS Cohort Study (MACS). Neurology 1999; 52:1640-1647.
5. Chang L, Ernst T, Leonido-Yee M, Witt M, Speck O, Walot I, et al. Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia. Neurology 1999; 53: 782-789.
6. Stankoff B, Tourbah A, Suarez S, Turell E, Stievenart J, Payan C, et al. Clinical and spectroscopic improvement in HIV-associated cognitive impairment. Neurology 2001; 56:112-115.
7. Chang L, Ernst T, Poland R, Jenden D. In vivo proton magnetic resonance spectroscopy of the normal human aging brain. Life Sci 1996; 58:2049-2056.
8. Soher B, van Zijl P, Duyn J, Barker P. Quantitative proton MR spectroscopic imaging of the human brain. Magn Reson Med 1996; 35:356-363.
9. Pfefferbaum A, Adalsteinsson E, Spielman D, Sullivan EV, Lim KO. In vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: effects of normal aging. Magn Reson Med 1999; 41:276-284.
10. Angelie E, Bonmartin A, Boudraa A, Gonnaud P, Mallet J, Sappey-Marinier D. Regional differences and metabolic changes in normal aging of the human brain: proton MR spectroscopic imaging study. Am J Neuroradiol 2001; 22:119-127.
11. Schuff N, Ezekiel F, Gamst AC, Amend DL, Capizzano AA, Maudsley AA, et al. Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging. Magn Reson Med 2001; 45:899-907.
12. Leary S, Brex P, MacManus D, Parker G, Barker G, Miller D, et al. A (1)H magnetic resonance spectroscopy study of aging in parietal white matter: implications for trials in multiple sclerosis. Magn Reson Imag 2000; 18:455-459.
13. Saunders D, Howe F, van den Boogaart A, Griffiths J, Brown M. Aging of the adult human brain: in vivo quantitation of metabolite content with proton magnetic resonance spectroscopy. J Magn Reson Imag 1999; 9:711-716.
14. Brooks J, Roberts N, Kemp G, Gosney M, Lye M, Whitehouse G. A proton magnetic resonance spectroscopy study of age-related changes in frontal lobe metabolite concentrations. Cerebr Cortex 2001; 11:598-605.
15. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod C, editor. New York: Columbia University Press; 1949. pp. 199-205.
16. Power C, Johnson RT. HIV-1 associated dementia: clinical features and pathogenesis. Can J Neurol Sci 1995; 22:92-100.
17. Price R, Brew B. The AIDS dementia complex. J Infect Dis 1988; 158:1079-1083.
18. Aronow HA, Brew BJ, Price RW. The management of the neurological complications of HIV infection and AIDS. Acquired Immune Defic Syndr 1988; 2:151-159.
19. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann NY Acad Sci 1987; 508:333-348.
20. Ernst T, Chang L. Elimination of artifacts in short echo time 1H MR spectroscopy of the frontal lobe. Magn Reson Med 1996; 36:462-468.
21. Kreis R, Ernst T, Ross BD. Absolute quantitation of water and metabolites in the human brain. II: metabolite concentrations. J Magn Reson 1993; B102:9-19.
22. Ernst T, Kreis R, Ross BD. Absolute quantitation of water and metabolites in the human brain. I: compartments and water. J Magn Reson 1993; B102:1-8.
23. Terry R, DeTeresa R, Hansen L. Neocortical cell counts in normal human adult aging. Ann Neurol 1987; 21:530-539.
24. Hansen L, Armstrong D, Terry R. An immunohistochemical quantification of fibrous astrocytes in the aging human cerebral cortex. Neurobiol Aging 1987; 8:1-6.
25. Nichols R, Day J, Laping N, Johnson S, Finch C. GFAP mRNA increases with age in rat and human brain. Neurobiol Aging 1993; 14:421-429.
26. Nichols N. Glial responses to steroids as markers of brain aging. J Neurobiol 1999; 40:585-601.
27. Meyerhoff D, Bloomer C, Cardenas V, Norman D, Weiner M, Fein C. Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients. Neurology 1999; 52:995-1003.
28. Conant K, Garzino-Demo A, Nath A, McArthur J, Halliday W, Power C, et al. Induction of monocyte chemoattractant protein-1 in HIV-1 tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci U S A 1998; 95:3117-3121.
29. Weiss J, Nath A, Major E, Berman J. HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes. J Immunol 1999; 163:2953-2959.
30. McManus C, Weidenheim K, Woodman S, Nunez J, Hesselgesser J, Nath A, et al. Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation. Am J Pathol 2000; 156: 1441-1453.
31. Adle-Biassette H, Chretien F, Wingertsmann L, Hery C, Ereau T, Scaravilli F, et al. Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol Appl Neurobiol 1999; 25:123-133.
32. Aylward EH, Henderer JD, McArthur JC, Brettschneider PD, Harris GJ, Barta PE, et al. Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology 1993; 43:2099-2104.
33. Mrak R, Griffin S, Graham D. Aging-associated changes in human brain. J Neuropathol Exp Neurol 1997; 56:1269-1275.
34. Volkow N, Ding Y, Fowler J, Wang G, Logan J, Gatley S, et al. Dopamine transporters decrease with age. J Nucl Med 1996; 37:554-559.
35. Rinne J, Hietala J, Ruotsalainen U, Sako E, Laihinen A, Nagren K, et al. Decrease in human striatal dopamine D2 receptor density with age: a PET study with [11C]raclopride. J Cerebr Blood Flow Metab 1993; 13:310-314.
36. Volkow N, Gur R, Wang G, Fowler J, Moberg P, Ding Y, et al. Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am J Psychiatry 1998; 155:344-349.
37. Lipton S. Similarity of neuronal cell injury and death in AIDS dementia and focal cerebral ischemia: potential treatment with NMDA open-channel blockers and nitric oxide-related species. Brain Pathol 1996; 6:507-517.
38. Berger JR, Kumar M, Kumar A, Fernandez J, Levin B. Cerebrospinal fluid dopamine in HIV-1 infection. Acquired Immune Defic Syndr 1994; 8:67-71.
39. Shaywitz SE, Shaywitz BA, Pugh KR, Fulbright RK, Skudlarski P, Mencl WE, et al. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA 1999; 281:1197-1202.
40. Maki PM, Resnick SM. Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiol Aging 2000; 21:373-383.
41. Ernst T, Chang L, Cooray D, Salvador C, Jovicich J, Walot I, et al. The effects of tamoxifen and estrogen on brain metabolism in elderly women. J Natl Cancer Inst 2002; 94:592-597.